SCHEMBL9769831

SCHEMBL9769831

O=CC(=C(c1ccc(F)cc1)c1ccc(F)cc1)n1nnnc1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
HPGD P15428 1/20 0.42
HMGCR P04035 1/20 0.39
HSD11B1 P28845 2/20 0.38
MGLL Q99685 1/20 0.38
HDAC6 Q9UBN7 1/20 0.37
MGAM O43451 1/20 0.36
AMY1A P0DUB6 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
NPC1 O15118 2/20 0.36
PKM P14618 1/20 0.35
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SLC6A2 P23975 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9769841 0.88 HMGCR (0.41) ALDH1A1HPGDHMGCRHSD11B1MGLL
SCHEMBL9769846 0.88 HMGCR (0.41) ALDH1A1HPGDHMGCRHSD11B1MGLL
SCHEMBL9769874 0.81 HMGCR (0.54) ALDH1A1HPGDHMGCRHSD11B1MGAM
SCHEMBL9769894 0.78 ALDH1A1 (0.43) ALDH1A1HPGDHMGCRHSD11B1MGLL
SCHEMBL10437581 0.76 HMGCR (0.53) ALDH1A1HPGDHMGCRHSD11B1HDAC6
SCHEMBL10437579 0.76 HMGCR (0.53) ALDH1A1HPGDHMGCRHSD11B1HDAC6
SCHEMBL9769883 0.74 HMGCR (0.77) HMGCR
SCHEMBL9769879 0.74 HMGCR (0.77) HMGCR
SCHEMBL9769828 0.74 ELANE (0.43) ALDH1A1HPGDHSD11B1MGLLHDAC6
SCHEMBL9769858 0.72 HMGCR (0.51) ALDH1A1HPGDHMGCRKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5070206-A INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE; ANTICHOLESTEROL, ANTILIPEMIC BRISTOL-MYERS COMPANY (US) 1991-12-03 US disclosed
US-5010205-A Antihypercholesterolemic tetrazol-1-yl intermediates BRISTOL-MYERS COMPANY (US) 1991-04-23 US disclosed
EP-0355820-A1 Antihypercholesterolemic tetrazol-1-yl compounds Bristol-Myers Squibb Company (US) 1990-02-28 EP disclosed
US-4870187-A ANTILIPEMIC, ATHEROSCLEROSIS BRISTOL-MYERS COMPANY (US) 1989-09-26 US disclosed